Publications by authors named "Luana Calabro"

Claim this Profile
K
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.
Antonio De Falco, Piera Grisolia, Raffaella Giuffrida, Clara Iannarone, Cinzia Graziano

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020).
Francesco Facchinetti, Andrea Camerini, Chiara Bennati, Paola Bordi, Elisa De Carlo

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).
Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, Luca Moscetti, Andrea Vingiani

Tumori· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy.
Maria Fortunata Lofiego, Rossella Tufano, Emma Bello, Laura Solmonese, Francesco Marzani

J Exp Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.
Alberto Bongiovanni, Chiara Liverani, Flavia Foca, Francesca Bergamo, Silvana Leo

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini, Luana Calabro

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis.
Monica Valente, Maura Colucci, Virginia Vegni, Valentina Croce, Cristiana Bellan

Onco Targets Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report.
Donato Michele Cosi, Cristina Fragale, Chiara Magri, Aldo Carnevale, Antonella Ciancetta

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Andrea Camerini, Francesca Mazzoni, Vieri Scotti, Carmelo Tibaldi, Andrea Sbrana

J Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial" [Eur J Cancer 199 (2024) 113531].
Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial.
Anna Maria Di Giacomo, Vanna Chiarion-Sileni, Michele Del Vecchio, Pier Francesco Ferrucci, Michele Guida

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.
Luana Calabrò, Giuseppe Bronte, Federica Grosso, Luigi Cerbone, Angelo Delmonte

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors.
Giuseppe Bronte, Alessia Belloni, Luana Calabrò, Lucio Crinò

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.
Federica Frascaro, Nicola Bianchi, Federico Sanguettoli, Federico Marchini, Sofia Meossi

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis.
Giuseppe Bronte, Luana Calabrò, Fabiola Olivieri, Antonio Domenico Procopio, Lucio Crinò

Clin Exp Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?
Giuseppe Bronte, Donato Michele Cosi, Chiara Magri, Antonio Frassoldati, Lucio Crinò

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Laura Mercatali, Silvia Vanni, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi

Front Bioeng Biotechnol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines.
Anna M Di Giacomo, Gianluca Giacobini, Gabriele Anichini, Claudia Gandolfo, Vincenzo D'alonzo

Eur J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer.
Lucia Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.
Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.
Elena Pancisi, Anna Maria Granato, Emanuela Scarpi, Laura Ridolfi, Silvia Carloni

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic Features.
Anna M Di Giacomo, Andrea Guarnieri, Sergio A Tripodi, Marta Maccari, Nicoletta Mancianti

J Immunother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Hedy L Kindler, Silvia Novello, Alessandra Bearz, Giovanni L Ceresoli, Joachim G J V Aerts

Lancet Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy.
Maria Fortunata Lofiego, Sara Cannito, Carolina Fazio, Francesca Piazzini, Ornella Cutaia

Epigenomes· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID and Lung Cancer.
Luana Calabrò, Giulia Rossi, Alessia Covre, Aldo Morra, Michele Maio

Curr Oncol Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis